Description
Retatrutide is a triple agonist targeting GLP-1, GIP, and glucagon receptors. Phase 2/3 trials show superior weight reduction versus dual agonists. 10 mg research vial.
For research use only. Not for human consumption.
$49.90
Triple receptor agonist · GLP-1 / GIP / Glucagon · next-gen GLP
Specification: 10 mg / vial
Availability: Usually ships within 2 days.
Structured product, pathway, quality-documentation, and laboratory-handling information.
BAC Water 3 mlSKU: BW3$4.90Add
BAC Water 10 mlSKU: BW10$13.90Add
Syringes 5× 1 ml U-100SKU: SYR5$2.49AddRetatrutide is a triple agonist targeting GLP-1, GIP, and glucagon receptors. Phase 2/3 trials show superior weight reduction versus dual agonists. 10 mg research vial.
For research use only. Not for human consumption.
Reviews
There are no reviews yet.